Cargando…
Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
The use of molecular-targeted drugs in the treatment of gastric cancer is increasing. However, the variety of molecular-targeted drugs in gastric cancer is still limited, and the development of new molecular-targeted therapies is required. The effect of combining sunitinib (SUN) with pterostilbene (...
Autores principales: | Hojo, Yudai, Kishi, Shingo, Mori, Shiori, Fujiwara-Tani, Rina, Sasaki, Takamitsu, Fujii, Kiyomu, Nishiguchi, Yukiko, Nakashima, Chie, Luo, Yi, Shinohara, Hisashi, Kuniyasu, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999764/ https://www.ncbi.nlm.nih.gov/pubmed/35409367 http://dx.doi.org/10.3390/ijms23074002 |
Ejemplares similares
-
Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020) -
Anti-Stem Cell Property of Pterostilbene in Gastrointestinal Cancer Cells
por: Mori, Shiori, et al.
Publicado: (2020) -
Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism
por: Fujiwara-Tani, Rina, et al.
Publicado: (2022) -
Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinoma
por: Matsushima-Otsuka, Sayako, et al.
Publicado: (2018) -
BRAF Mutation Is Associated with Hyperplastic Polyp-Associated Gastric Cancer
por: Fujiwara-Tani, Rina, et al.
Publicado: (2021)